Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Investing

AbbVie : ABBV

All AbbVie Articles

583 Articles

Austin Smith | May 7, 2026 at 5:24 PM EDT

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

Schwab U.S. Dividend Equity ETF (NYSEARCA: SCHD) and Vanguard High Dividend Yield ETF (NYSEARCA: VYM) sit on most income investors’…

Vandita Jadeja | May 6, 2026 at 10:32 AM EDT

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

Dividend income arrives whether markets rally or sell off. For investors seeking recurring cash flow, high-yield equities remain the cleanest…

Vandita Jadeja | May 4, 2026 at 8:55 AM EDT

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

Dividend stocks can be a pillar for long-term investing, generating passive income and offering stability even during tough environments. The…

Vandita Jadeja | Apr 30, 2026 at 10:40 AM EDT

Price Prediction: Why AbbVie’s Post-Humira Pivot Makes It a Strong Buy

Our AbbVie (NYSE:ABBV | ABBV Price Prediction) call lands on the constructive side of the ledger after a noisy but…

Lee Jackson | Apr 30, 2026 at 7:49 AM EDT

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Pre-Market Stock Futures: Futures are trading higher this morning after a messy Wednesday trading session that saw all major indices…

John Seetoo | Apr 25, 2026 at 6:35 AM EDT

Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital

Income investors shopping the healthcare aisle often land on Gabelli Healthcare & WellnessRx Trust (NYSE:GRX), a closed-end fund managed by…

Vandita Jadeja | Apr 23, 2026 at 4:04 PM EDT

These 5 Stocks Pay You Even When You’re Sleeping

Market volatility in 2026 has reminded investors that earned income alone is fragile. When tariff fears rattle equities and economic…

David Beren | Apr 21, 2026 at 3:34 PM EDT

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn

Gabelli Dividend & Income Trust (NYSE:GDV) trades near $29 and pays a $0.15 monthly distribution, up from $0.11 per month…

David Moadel | Apr 21, 2026 at 10:30 AM EDT

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

One of Wall Street’s top firms just made the bull case for AbbVie (NYSE:ABBV | ABBV Price Prediction) stock, initiating…

Vandita Jadeja | Apr 20, 2026 at 10:37 AM EDT

Why I Can’t Stop Buying AbbVie Stock

AbbVie (NYSE:ABBV | ABBV Price Prediction) has attracted persistent buying interest, and every pullback has drawn in value-focused investors. The…

Vandita Jadeja | Apr 17, 2026 at 10:22 AM EDT

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record…

David Moadel | Apr 7, 2026 at 9:58 AM EDT

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

AbbVie (NYSE:ABBV | ABBV Price Prediction) stock has pulled back 12% over the past month, sliding to around $204. JPMorgan…

Vandita Jadeja | Apr 6, 2026 at 12:15 PM EDT

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two…

Lee Jackson | Apr 2, 2026 at 8:10 AM EDT

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

With inflation back in the economic picture, simply getting a dependable income stream may not be the best strategy for…

John Seetoo | Mar 27, 2026 at 11:49 AM EDT

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

Retirees and income-focused investors have long used Vanguard Value ETF (NYSEARCA:VTV) as a core portfolio anchor, drawn to its dividend…

1 2 3 4 … 39

AbbVie : ABBV

All AbbVie Articles

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

Price Prediction: Why AbbVie’s Post-Humira Pivot Makes It a Strong Buy

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital

These 5 Stocks Pay You Even When You’re Sleeping

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

Why I Can’t Stop Buying AbbVie Stock

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

AbbVie : ABBV

All AbbVie Articles

Vanguard High Dividend Yield ETF Delivers 67% Five-Year Returns Against Schwab U.S. Dividend Equity ETF’s Steadier 229% Decade Gain

6 Pharma Dividend Stocks Yielding Up to 6.44% — and They’ve Survived Every Market Crash

10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

Price Prediction: Why AbbVie’s Post-Humira Pivot Makes It a Strong Buy

Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, Equinix, GE Healthcare, Kratos Defense, Meta Platforms, Oneok, Palantir Technologies, Wingstop, and More

Healthcare CEF Insiders Are Quietly Buying While 60% of Distributions Return Capital

These 5 Stocks Pay You Even When You’re Sleeping

GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn

Canaccord Calls AbbVie a Core Holding With a $262 Target: Is This Biopharma’s Most Durable Compounder?

Why I Can’t Stop Buying AbbVie Stock

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie Gets JPMorgan Buying Opportunity Call With $260 Price Target Amid Competitive Concerns

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

The 5 Safest Dividend Aristocrats Are Perfect For Retirees Needing Growth & Income

Why Income Investors Keep VTV as a Core Portfolio Anchor in a Turbulent 2026

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation